Co-Diagnostics Inc. (CODX)

Name: Co-Diagnostics Inc. (CODX) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Co-Diagnostics Inc. (CODX)

Stock Card

$1.22

$-0.04 (-3.17%)

As on 28-Aug-2026 16:00EDT

Market cap

$8 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

P/B Ratio

0.7

Div. Yield

0 %

Co-Diagnostics (CODX) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 1.18 High: 1.29

52 Week Range

Low: 0.94 High: 46.50

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-1.7 %
ROCE

-- %
Industry P/E

44.46
EV/EBITDA

0.5
Debt to Equity

0
Book Value

$2.6
EPS

$-29.5
Face value

--
Shares outstanding

6,981,319

10 Years Aggregate

CFO

$37.15 Mln

EBITDA

$18.96 Mln

Net Profit

$5.25 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Co-Diagnostics (CODX)	-75.9	-40.2	-83.3	-87.5	-67.5	-67.3	--
BSE Sensex	-8.8	0.6	1.8	-4.4	6.0	6.6	10.8
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 28-Aug-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022	2021	2020	2019
Co-Diagnostics (CODX)	-77.5	-43.3	-47.2	-71.8	-4.0	938.9	-39.9
S&P Small-Cap 600	4.0	7.0	13.9	-17.4	25.3	9.6	20.9
BSE Sensex	9.1	8.1	18.7	4.4	22.0	15.8	14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Co-Diagnostics (CODX)	1.2	8.5	0.7	-47.1	-6,727.6	-282.3	--	0.7
10X Genomics Inc (TXG)	61.5	8,018.1	616.9	-75.1	1.7	-9.3	--	10.2
Avantor (AVTR)	14.6	9,638.1	6,561.1	-578.0	-4.5	-10.3	--	1.7
Bio-Rad Laboratories	365.1	9,761.6	2,589.3	222.4	-6.0	3	44.5	1.3
Bruker (BRKR)	57.1	8,696.7	3,499.6	-71.2	0.5	-3.2	--	3.8
Glaukos Corp (GKOS)	179.9	10,905.5	612.8	-188.1	-30.6	-28.1	--	16.4
Lantheus Holdings (LNTH)	100.8	6,577.5	1,556.3	275.3	24.6	22.9	24.1	5.0
Merit Medical Systems (MMSI)	90.5	5,403.2	1,579.2	145.6	14.3	8.9	37.2	3.2
Penumbra (PEN)	321.7	12,752.7	1,504.9	160.6	13.6	10.9	79.4	8.4
Repligen (RGEN)	176.3	9,947.9	785.1	41.5	9.9	2	251.8	4.9

Shareholding Pattern

View Details

About Co-Diagnostics (CODX)

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and... internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. Co-Diagnostics, Inc. was incorporated in 2013 and is based in Salt Lake City, Utah. Read more

Chairman & CEO

Mr. Dwight H. Egan
Chairman & CEO

Mr. Dwight H. Egan
Headquarters

Salt Lake City, UT
Website

https://co-dx.com

FAQs for Co-Diagnostics (CODX)

What is the current share price of Co-Diagnostics Inc (CODX) Today?

The share price of Co-Diagnostics Inc (CODX) is $1.22 (NASDAQ) as of 28-Aug-2026 16:00 EDT. Co-Diagnostics Inc (CODX) has given a return of -67.55% in the last 3 years.

What is the current PB & PE ratio of Co-Diagnostics Inc (CODX)?

Since, TTM earnings of Co-Diagnostics Inc (CODX) is negative, P/E ratio is not available.
The P/B ratio of Co-Diagnostics Inc (CODX) is 0.69 times as on 28-Aug-2026, a 82 discount to its peers’ median range of 3.79 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2025	0.00	0.01
2024	-0.02	0.02
2023	-0.04	0.02
2022	-0.18	0.02
2021	0.24	0.07

What is the 52 Week High and Low of Co-Diagnostics Inc (CODX)?

The 52-week high and low of Co-Diagnostics Inc (CODX) are Rs 46.50 and Rs 0.94 as of 31-Aug-2026.

What is the market cap of Co-Diagnostics Inc (CODX)?

Co-Diagnostics Inc (CODX) has a market capitalisation of $ 8 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in Co-Diagnostics Inc (CODX)?

Before investing in Co-Diagnostics Inc (CODX), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.